Home > Insider Trading > Filing (0001209191-15-086217)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1493566	Otonomy Inc.	OTIC	Pharmaceutical Preparations (2834)	262590070

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1615234	E Paul Cayer	C/O Otonomy, Inc. 6275 Nancy Ridge Drive, Suite 100 San Diego CA 92121	Ch. Financial & Business Offcr	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-12-17	3,000	$6.33	12,610	No	4	M	Direct
Common Stock	Disposition	2015-12-17	2,700	$29.65	9,910	No	4	S	Direct
Common Stock	Disposition	2015-12-17	300	$30.19	9,610	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee stock option (right to buy)	Disposition	2015-12-17	3,000	$0.00	3,000	$6.33

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
77,492		2024-06-03	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The sale price reported in Column 4 of Table I represents the weighted average sale price of the shares sold ranging from $29.13 to $30.10 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in Column 4 of Table I represents the weighted average sale price of the shares sold ranging from $30.13 to $30.28 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
One-fourth (1/4) of the shares subject to the option vested on April 23, 2015 and one forty-eighth of the shares vest monthly thereafter.
In addition to the option to purchase 77,492 shares of common stock as set forth in Table II, the Reporting Person currently holds options to purchase up to an aggregate of 255,391 shares of common stock, which options vest according to their terms.